Profiles
Professor Philip Debruyne
Honorary Associate Professor (Reader) in Cancer Care
School of Nursing and Midwifery (Faculty of Health)
Biography
Biography
Philip R. Debruyne, MD, PhD, MSc, DABCP (CP), FRCP(Glasg), FCP is a Consultant Medical Oncologist, Clinical Pharmacologist & Lead Clinician at the OECI-designated Kortrijk Cancer Centre of az groeninge (Kortrijk, Belgium; since 2008) with as specialty interests : Gynaecologic, Head & Neck and Urologic cancers and Geriatric Oncology. Since 2016 he serves as an Honorary Visiting Professor of Anglia Ruskin University (Medical Technology Research Centre (MTRC), School of Life Sciences, Cambridge, UK) and since 2021 as an Honorary Associate Professor (Reader) in Cancer Care at the School of Nursing and Midwifery (Faculty of Health) of the University of Plymouth, UK.
He was born October 5th 1971 in Bruges. He received the degrees: Physician (Ghent University; 1996), standard ECFMG certificate + FSMB USMLE step 3 (MD equivalent; 1997 & 2004; USA), PhD in Medical Sciences (Ghent University; 2002) and MSc in Pharmacology (Human Investigation; Thomas Jefferson University, Philadelphia, USA; 2005). During and after completing an internship and residency training at Ghent University Hospital (1996-2002), he spent: 4 years (1997-2001) at the Laboratory of Experimental Cancer Research of the Department of Radiotherapy and Nuclear Medicine (Ghent University) as a Research Associate, 2 years (2002-2004) at the Division of Clinical Pharmacology of the Sidney Kimmel Cancer Center at Thomas Jefferson University (Philadelphia, USA) as a Post-doctoral Fellow in Clinical Pharmacology and two years at the Department of General Medical Oncology of the Leuven University Hospitals as a Clinical Fellow in Medical Oncology. He obtained board certifications in Internal Medicine (Ghent University; 2004), Clinical Pharmacology (American Board of Clinical Pharmacology; 2005) and Medical Oncology (Leuven University; 2006). Prior to joining az groeninge Hospital in 2008, he held the positions of Clinical Senior Lecturer in Medical Oncology (Clinical Trials; 2006-2008) in the Department of Cancer Sciences and Molecular Pathology of the University of Glasgow (UK) and the position of Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre in Glasgow (2006-2008). From 2013 to 2016 he was an Honorary Senior Fellow with the School of Health & Social Care of the University of Greenwich in London (UK)) were he led the Ageing & Cancer Research Cluster within the Centre for Positive Ageing.
Dr Debruyne was the recipient of a Sportvereniging tegen Kanker award (1998), the the two-year Merck Sharp & Dohme International Fellowship in Clinical Pharmacology Award (2002-2004), an Honorary Belgian American Educational Foundation (BAEF) Fellowship (2003), the 5th Pfizer Oncology Award 2020 and grants from: Bijzonder Onderzoeksfonds (BOF) Universiteit Gent, Vlaamse Kanker Liga, West Research Endowment Fund (UK), Pfizer (educational grant), Federale Overheidsdienst Volksgezondheid, Veiligheid van de VoedselKeten en Leefmilieu (Belgian Federal Government/National Cancer Plan), Kom Op Tegen Kanker (KOTK, Belgium), King Baudouin Foundation (KBF, Belgium) and Belgian Foundation against Cancer. He is a Fellow of the Royal College of Physicians & Surgeons of Glasgow qua Physician (FRCP), a Fellow of the American College of Clinical Pharmacology (FCP) and member of numerous scientific societies and cooperative groups such as the European Organisation for Research and Treatment of Cancer (EORTC QoL group; EORTC GUCG representative in Older Adult Council, OAC), Belgian Society of Medical Oncology (BSMO; Survivorship Task Force) and a former member of both the Committee and Panel of the National Cancer Research Network (NCRN; UK) Chemotherapy and Pharmacy Advisory Service (CPAS). He was founding board member of the Kortrijk Oncology Fund charity within the King Baudouin Foundation (KBF). He previously served as associate editor of European Journal of Cancer Care and BMC Pharmacology and Toxicology and as guest editor for other journals. He serves since 2021 as (Substitute) Board Member (with experience in phase 1 trials) of the Clinical Trials College (Federal Public Service (FPS) Health, Food chain safety and Environment, Belgium).
Publications
Publications
Key publications
Key publications are highlighted
Journals